# Clinical Investigation Using MED3000 Gel or Tadalafil Tablets in the Treatment of Erectile Dysfunction

> **NCT04984993** · PHASE3 · COMPLETED · sponsor: **Futura Medical Developments Ltd.** · enrollment: 116 (actual)

## Conditions studied

- Erectile Dysfunction

## Interventions

- **DEVICE:** MED3000 (Male)
- **DRUG:** Tadalafil 5mg (Male)
- **DEVICE:** MED3000 (Female)
- **DRUG:** Tadalafil 5mg (Female)

## Key facts

- **NCT ID:** NCT04984993
- **Lead sponsor:** Futura Medical Developments Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-14
- **Primary completion:** 2022-07-13
- **Final completion:** 2022-07-13
- **Target enrollment:** 116 (ACTUAL)
- **Last updated:** 2023-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04984993

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04984993, "Clinical Investigation Using MED3000 Gel or Tadalafil Tablets in the Treatment of Erectile Dysfunction". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT04984993. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*